Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Pharmacol., 10 June 2025

Sec. Experimental Pharmacology and Drug Discovery

Volume 16 - 2025 | https://doi.org/10.3389/fphar.2025.1611105

Corrigendum: Neuroprotective effects of a novel peptide through the Rho-integrin-Tie2 and PI3K/Akt pathways in experimental autoimmune encephalomyelitis model

This article is a correction to:

  1. Neuroprotective effects of a novel peptide through the Rho-integrin-Tie2 and PI3K/Akt pathways in experimental autoimmune encephalomyelitis model

    1. Read original article
Wen ZhouWen Zhou1Han QuHan Qu2Xiao-Xiao FuXiao-Xiao Fu3Miao-Miao XuMiao-Miao Xu4Qiang Li Qiang Li1*Yuan Jiang Yuan Jiang5*Shu Han Shu Han2*
  • 1Department of Emergency Medicine, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China
  • 2Institute of Anatomy and Cell Biology, Medical College, Zhejiang University, Hangzhou, China
  • 3Institute of Human Anatomy, Histology and Embryology, Basic Medical College, Zhejiang Chinese Medical University, Hangzhou, China
  • 4Department of Rehabilitation in Traditional Chinese Medicine, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China
  • 5Department of Pulmonology, Children’s Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China

A Corrigendum on:
Neuroprotective effects of a novel peptide through the Rho-integrin-Tie2 and PI3K/Akt pathways in experimental autoimmune encephalomyelitis model

by Zhou W, Qu H, Fu X-X, Xu M-M, Li Q, Jiang Y and Han S (2024). Front. Pharmacol. 15:1290128. doi: 10.3389/fphar.2024.1290128

In the published article, there was an error in Supplementary Figure S7 as published. The magnification of Supplementary Figure S7S is different from others. This has been corrected.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: C16, EAE, Tie2, integrin, PI3K/Akt pathways

Citation: Zhou W, Qu H, Fu X-X, Xu M-M, Li Q, Jiang Y and Han S (2025) Corrigendum: Neuroprotective effects of a novel peptide through the Rho-integrin-Tie2 and PI3K/Akt pathways in experimental autoimmune encephalomyelitis model. Front. Pharmacol. 16:1611105. doi: 10.3389/fphar.2025.1611105

Received: 13 April 2025; Accepted: 29 May 2025;
Published: 10 June 2025.

Edited and reviewed by:

C. James Chou, Medical University of South Carolina, United States

Copyright © 2025 Zhou, Qu, Fu, Xu, Li, Jiang and Han. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Yuan Jiang, eXVhbmoyMTJAemp1LmVkdS5jbg==; Qiang Li, emp1bGlxaWFuZ0Bob3RtYWlsLmNvbQ==, emp1bGlxaWFuZ0B6anUuZWR1LmNu; Shu Han, aGFuMDBzaHVAemp1LmVkdS5jbg==

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.